Your current location is:{Current column} >>Text

Walmart, Chevron, Adobe rise premarket; Johnson & Johnson, Carvana fall By

{Current column}5People have watched

Introduction-- U.S. edged higher Monday, at the start of a week that includes more earnings from tech giants as ...

-- U.S. edged higher Monday,mt4 foreign exchange rebate website at the start of a week that includes more earnings from tech giants as well as the important monthly jobs report.

Here are some of the biggest premarket U.S. stock movers today:

Walmart, Chevron, Adobe rise premarket; Johnson & Johnson, Carvana fall By

  • Walmart(NYSE:) stock rose 0.3% after the Wall Street Journal reported that the retail giant has further cemented its interest in Flipkart through a $1.4 billion purchase of shares from a major investor in the Indian e-commerce group.

  • Johnson & Johnson(NYSE:) stock fell 1.7% after a U.S. judge dismissed the drugmaker's second attempt to resolve tens of thousands of lawsuits over its talc products.

  • (NYSE:) stock rose 1.6% after Goldman Sachs upgraded its stance on the oil major to ‘Buy’ from ‘Neutral’, seeing the potential for strong future growth.

  • Adobe(NASDAQ:) stock rose 2.5% after Morgan Stanley upgraded the computer software company to ‘Overweight’ from ‘Equal weight’, citing potential upside from Generative AI.

  • (NYSE:) stock fell 1.5% after Jefferies downgraded the online used car retailer to ‘Underperform’ from Hold’, saying the company’s current tailwinds aren’t sustainable.

  • SoFi Technologies(NASDAQ:) stock rose 3.7% after the online personal finance company easily beat revenue expectations in its , while reporting a narrower-than-expected loss.

  • Wayfair(NYSE:) stock rose 8.2% after Piper Sandler upgraded the e-commerce company to ‘Overweight’ from 'Neutral', citing improving sales, rising market share, and an attractive valuation.

  • Quest Diagnostics(NYSE:) stock rose 0.5% after the medical laboratories company launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein.

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!

Tags:

Related articles